Birgit Michels
Overview
Explore the profile of Birgit Michels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
364
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derigs P, Schubert M, Dreger P, Schmitt A, Yousefian S, Haas S, et al.
Leukemia
. 2024 Aug;
38(11):2419-2428.
PMID: 39192036
Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We...
2.
Schubert M, Schmitt A, Huckelhoven-Krauss A, Neuber B, Kunz A, Waldhoff P, et al.
J Hematol Oncol
. 2023 Jul;
16(1):79.
PMID: 37481608
Background: Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2...
3.
Schubert M, Kunz A, Schmitt A, Neuber B, Wang L, Huckelhoven-Krauss A, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33007926
Chimeric antigen receptor (CAR) T cell (CART) therapy has been established as a treatment option for patients with CD19-positive lymphoid malignancies in both the refractory and the relapsed setting. Displaying...
4.
Michels B, Franke K, Weiglein A, Sultani H, Gerber B, Wessjohann L
J Exp Biol
. 2020 Aug;
223(Pt 16).
PMID: 32848044
Preparations of root are widely used in traditional medicine. They can increase life span in worms and flies, and have various effects related to nervous system function in different animal...
5.
Kunz A, Gern U, Schmitt A, Neuber B, Wang L, Huckelhoven-Krauss A, et al.
Mol Ther Methods Clin Dev
. 2020 Mar;
17:448-454.
PMID: 32201711
Chimeric antigen receptor (CAR) T cells are considered genetically modified organisms (GMOs) and constitute gene therapy medicinal products. Thus, CAR T cell manufacturing for clinical application is strictly regulated. Appropriate...
6.
Schubert M, Schmitt A, Sellner L, Neuber B, Kunz J, Wuchter P, et al.
BMJ Open
. 2019 May;
9(5):e026644.
PMID: 31110096
Introduction: Chimeric antigen receptor (CAR) T cells spark hope for patients with CD19+ B cell neoplasia, including relapsed or refractory (r/r) acute lymphoblastic leukaemia (ALL) or r/r non-Hodgkin's lymphoma (NHL)....
7.
Wang L, Gong W, Wang S, Neuber B, Sellner L, Schubert M, et al.
Cytotherapy
. 2019 Mar;
21(5):566-578.
PMID: 30910382
Background: Chimeric antigen receptor engineered T (CAR-T) cell therapy is a promising approach currently revolutionizing the field of cancer immunotherapy. However, data concerning clinical-grade CAR-T cell stability and functionality after...
8.
Coors A, Brosch M, Kahl E, Khalil R, Michels B, Laub A, et al.
J Ethnopharmacol
. 2019 Feb;
235:320-328.
PMID: 30776471
Aim Of The Study: In this context, our study aimed to examine potential antipsychotic-like effects of R. rosea root extract. Materials And Methods: We tested the effects of R. rosea...
9.
Michels B, Zwaka H, Bartels R, Lushchak O, Franke K, Endres T, et al.
Sci Adv
. 2018 Nov;
4(10):eaat6994.
PMID: 30417089
Cognitive impairments can be devastating for quality of life, and thus, preventing or counteracting them is of great value. To this end, the present study exploits the potential of the...
10.
Almeida-Carvalho M, Berh D, Braun A, Chen Y, Eichler K, Eschbach C, et al.
J Exp Biol
. 2017 Jul;
220(Pt 13):2452-2475.
PMID: 28679796
Mapping brain function to brain structure is a fundamental task for neuroscience. For such an endeavour, the larva is simple enough to be tractable, yet complex enough to be interesting....